A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in ashkenazi jews

American Journal of Human Genetics

Volumn 71, Issue 4, 2002, Pages 981-984

  Rennert, Hanna ^a   Bercovich, Dani ^a   Hubert, Ayala ^b   Abeliovich, Dvora ^b   Rozovsky, Uri ^a   Bar Shira, Anat ^a   Soloviov, Sonya ^a   Schreiber, Letizia ^a   Matzkin, Haim ^a   Rennert, Gad ^c   Kadouri, Luna ^b   Peretz, Tamar ^b   Yaron, Yuval ^a   Orr Urtreger, Avi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; NERVE PROTEIN; SYNTAXIN 1;

ARTICLE; FEMALE; FOUNDER EFFECT; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HUMAN; JEW; MALE; MUTATION; PROSTATE TUMOR;

ANTIGENS, SURFACE; FEMALE; FOUNDER EFFECT; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JEWS; MALE; MUTATION; NERVE TISSUE PROTEINS; PROSTATIC NEOPLASMS; SYNTAXIN 1;

EID: 19044373249     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/342775     Document Type: Article

References (15)

1. Berry R, Schroeder JJ, French AJ, McDonnell SK, Peterson BJ, Cunningham JM, Thibodeau SN, Schaid DJ (2000) Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 67:82-91
2. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wohr G, Latil A, et al (1998) Predisposing gene for early-onset prostate cancer, localized on chromosome lq42.2-43. Am J Hum Genet 62:1416-1424
3. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, et al (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30:181-184
4. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367-3371
5. Gavert N, Yaron Y, Naiman T, Bercovich D, Rozen P, Shomrat R, Legum C, Orr-Urtreger A (2002) Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat 19:664
6. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA (1980) The LNCaP cell line: a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37:115132
7. Hubert A, Peretz T, Manor O, Kaduri L, Wienberg N, Lerer I, Sagi M, Abeliovich D (1999) The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet 65:921-924
8. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17:79-83
9. Ostrander EA, Stanford JL (2000) Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 67:13671375
10. Rokman A, Ikonen T, Seppala EH, Nupponen N, Autio V, MononenN, Bailey-Wilson J, Trent], CarptenJ, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 70:1299-1304
11. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274:1371-1374
12. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200
13. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, et al (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27:172-180
14. Xu J, Meyefs D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, et al (1998) Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20:175179
15. Zhou A, Hassel BA, Silverman RH (1993) Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72:753-765